Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What major announcement do you suspect, Gsdubb?
Thank you
Thank you
Is there an upcoming webinar scheduled? I was under the impression one was planned for this week.
I have always appreciated your analysis, Gsdubb... it is a primary reason I started to post here. You have made a difference and your efforts have not been in vain. Thank you for all you do!
Again, thank you.
Amazing what the future holds for those that dare to believe. Very nice find, alsoconcerned... Thank you.
I am an interested investor...who very much believes that stem cell regeneration will change the landscape of medicine (IMO). I also believe there is an effort from the pharmaceutical and device industries to 'downplay' the potential due to conflicting interests and loyalties (IMO). I also believe Bioheart is at the forefront of this technological paradigm shift away from treating symptoms to providing a cure, which can only happen when the body heals itself (IMO). These are all my opinions...pretty good ones though, don't ya' think?
I will retract as you have requested...just trying to be polite. My bad!
I am not concerned at all by the NIH's position on stem cells...the vast majority of leading efforts are with the private sector, and the great news is...wait for it... Bioheart is leading the private sector in cardiovascular stem cell regeneration.
Would that mean, like a Bioheart, Gsdubb...I believe it would. Now that I do find interesting...how about you?
I have enjoyed the majority of my time on this forum...thank you iHub for providing an outlet for my opinions. My hope and prayer is that Bioheart changes the world for the better. If not, and things do not workout as envisioned, at least we believed in something good, a cause worth caring for. I'm grateful to everyone on here who has invested their time and treasure in this dream we share...As for me, I will continue to believe.
You mean as it appears you've been doing repeatedly for some time now...say the same thing, in a slightly different way. I'm sorry...I do not see the difference. IMO
I believe this may be off-topic . IMO
Excellent financial analysis, as always. What is your analysis of the science of stem cell regeneration?
I apologize if I missed your reply. What about the science of stem cell regeneration...are you a believer?
What about the science...do you believe in the science of stem cell regeneration?
I would like to first say thank you to the majority of investors who have taken their time to post thoughtful, insightful, and positive comments. Thank you to the moderators as well, and please, if I may request for my last post to not be deleted...thank you. I am grateful for this forum to have been able to express my heartfelt belief in Bioheart and the future of medicine. However, the time has come for me to wish all well and to say goodbye. This board should not be an exercise in defending that which does not require a defense...this company has led the way in cardiovascular stem cell research for a decade now, but that does not matter to some as it should. Yet, they are able to make baseless comments and challenge well-respected, long-time contributors while not being censored or reprimanded. I wish all whose desire to see millions of lives around the world improved because of Bioheart's leadership in the nascent field of tissue regeneration much success...you deserve to be rewarded and part of something much bigger than any one of us. For those that don't believe yet , at some point in time, I hope you do.
HeavenBound, I am sincerely happy for you that you have invested in Bioheart, albeit only a few days ago, and have found this forum and feel confident enough in your knowledge to post as you have. I'm suspecting you will take offense to what I'm about to say, but I'd prefer it if you did not. Gsdubb is a very well-respected poster and very knowledgeable investor on this board, and speaks with Mike Tomas, the CEO and President of Bioheart, frequently on our behalf...if he believes Bioheart will go to $15-$20 range in the future, that encourages almost everyone with any sense of history with stem cell research and the biotech industry to take note...he does know what he is talking about. We do not know for certain if you do for you've only been with us for, what, a day? So I highly encourage you to show a little more respect for someone that knows more about what we're all interested than a 'day-old poster' who thinks way more of himself than he should. Hope that came across exactly as it was meant to!
I don't mean to be disrespectful with my comments HeavenBound, so please forgive me if they come across as critical...they are only my passionately held opinions. This is partly what disturbs me regarding this board...analysis of Bioheart stock based on charts, graphs, etc. I understand the desire to do so if it was my profession, as it is for many here. It is not my profession...I have a salaried career that supports myself and my family. This stock is different to me...I 'fell in love' with Bioheart years ago and I'm as passionate a believer as I've ever been. After 10 years of faithfully watching this company progress, after challenge followed by pitfall followed by financial uncertainty, I still believe Bioheart is the future of medicine. My 'love affair' with this stock is based on years of intense research and years of measured investing. So many investors here see only the 'now', not what's coming. What is coming is potentially bigger than anything that has ever been seen in medicine before...therapies that CURE disease, not just treat their symptoms. What's not to 'love' about that?
I agree, Gsdubb. I've been following this company for more than 10 years now and an investor since the IPO in 2008. I have always believed this will be the company to change the course of cardiovascular medicine...recently, I have come to believe it will change ALL of medicine.
Miguelito, that is a very fair question to ask...and yes, a downturn is possible. The difference in this upwards trend compared to several in the recent past is the timing...connected to a positive trial result, not a pps climb without substantial news. But many may consider this the opportunity to make a small profit now instead of waiting for the bigger haul. I can only imagine what the day will look like after positive news is released from the stem cell industry leading Bioheart regarding the only Phase 3 trial, completed with life-changing results. Today's 'euphoria' will be eclipsed and when the major players will take note. Don't be discouraged if the answer to your question is not what you want to happen...in time, the REAL climb begins.
Thank you, Gsdubb.
A one billion dollar opportunity...tomorrow. The news was welcomed today as it highlights for all to see what is coming 'tomorrow'...adipose stem cells for post MI, cancer, even macular degenerative disease. Great news and thankful for it, but still news for a Phase 1 trial. Would not be surprised or disappointed if it trends downward this afternoon or tomorrow...but at some point, at some time in the future, when positive Myocell news is revealed from our Phase 3 Mirror trial, Bioheart stock will be the stock to own. These low prices are an amazing opportunity to buy 'potentially' one of the greatest success stories on Wall Street. The only news I'm looking for is 3-4 months away. You couldn't get me to sell my shares now no matter how hard you tried!
That's exactly right, andyshow...this is a 'big picture' stock. This amazing opportunity is for those few that can see the vision clearly now as if it's already a reality...not everyone is disciplined to do so. It takes patience and an appreciation for what is possible. The pioneer in any endeavor is the one that has the most to risk, but always the one that has the most to profit. I choose to be a pioneer.
Sometimes the best rebuttal to an unsubstantiated, 'apocalyptic' opinion is to make no comment...I believe that is what I'll choose to do.
Thank you, HybridTrader.
Yes it does.
Once again I agree completely with your analysis Gsdubb. There has not been news of substance that would change the momentum of this stock...positive news to trend it upward nor negative news to trend it downward. No news. This is why I've been encouraging all who believe in the promise of Bioheart to not become 'emotional' when viewing our investment...the unpredictable cycle will likely continue for some time until news of substance is revealed. If the news we are patiently ( I hope) awaiting regarding the Mirror trial is positive, no MM or short-investor will be able to stop the permanent pps climb upwards . If the opposite is true, then a downwards trend will be manifest. The caution for us is to not weight to much into our speculation, but to wait for definitive reasons to emerge...they will. They always do!
You are most welcome...and there is substantial evidence available to be as optimistic as you are. I join you as having a positive outlook for what could be.
I hope as all of you do that this steady increase in Bioheart stock value continues, but until an announcement that enrollment is complete in our Phase 3 (pivotal) Mirror trial, I am apprehensive to speculate as to the cause of our good fortune. News will be coming and will confirm for us the reason(s).
I appreciate your optimism andyshow...but I'm not certain the study you cited is reason for pps progress as of late. The clinical trial you referenced (Marvel part 1) has been put on hold strategically by the FDA, so as to not delay the approval and commercialization of MyoCell...the Mirror trial was initiated to temporarily replace enrollment efforts utilizing the bioheart MyoCath catheter for injections. There is intention to start Marvel part 2 in the future, but all efforts are now with the Mirror trial using myoblasts, and Angel using adipose setem cells. Angel is a Phase 1 trial and is much further from completion, while Mirror should be completed with enrollment no later than July 2014.
I did indeed. See post #4837...spot-on analysis Gsdubb!
Thank you Investaholic33...well done! I just finished listening to the entire webinar, including some 30 minutes of Q/A. I was familiar with some of the information that was discussed but not to the detail provided in this presentation. The webinar utilizes a terrific format to gain insight as to the potential this opportunity affords those that are willing to believe what is possible. I do not believe one can objectively listen/view the data and not come to a similar conclusion...it is that impressive!
Glad to hear you are well...StockLearner2011 and HybridTrader as well. Looking forward to blog from Mike as any information from our CEO is appreciated and welcomed insight.
My goodness it's been quiet here lately. I can't recall when a significant amount of time elapsed without a post or two...everyone ok?
Very true...and then there is the possibility BioLeonhardt's stem cell pump-device is utilized to also deliver MyoCell to necrotic myocardium. Things appear to be much more connected than at first glance. If investors do their due diligence and participate in quality research of the company, it's history in the stem cell arena, and the MyoCell technology (clinical trials to date, safety/efficacy results, etc.) it is difficult to not see the potential. One would have to be biased against proven factual information to determine otherwise.
I believe you are correct in your analysis...the FDA placed a hold on the request for 'Expanded Access' protocol using Myocell. They proposed it would likely interfere with the clinical development and potential approval of the treatment. That is one of the purposes of the Mirror trial, to continue a pivotal study and not affect one that is on hold and mirrors the existing pivotal study (Marvel)...there is intent to continue Marvel 2, but as I've stated previously, I believe the future of Myocell's approval and market commercialization hinges on Mirror. Another benefit, and one of only major differences between studies, is use of Bioheart's MyoCath catheter instead of JNJ's MyoStar...other than that, studies are near identical. Major takeaway for me is FDA proposed changes to not interfere with status of Myocell commercialization...suggests to me they are desiring approval and believe what we do about this technology.
Thank you as well, Gsdubb.
Thank you Gaintrader...your generous words are most appreciated.